3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
17
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Myelodysplastic Syndromes
15
Hematologic Neoplasms
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Lymphoma, Non-Hodgkin
6
Neuroblastoma
5
Leukemia, Biphenotypic, Acute
5
Myeloproliferative Disorders
4
Graft vs Host Disease
4
Multiple Myeloma
3
Medulloblastoma
3
Lymphoma, Large B-Cell, Diffuse
3
Leukemia
3
Hodgkin Disease
3
Ganglioneuroblastoma
3
Blastic Plasmacytoid Dendritic Cell Neoplasm
3
Lymphoma
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myelomonocytic, Chronic
2
Anemia, Refractory, with Excess of Blasts
2
Teratoma
1
Sarcoma, Myeloid
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Recurrence
1
Pyloric Stenosis, Hypertrophic
1
Pinealoma
1
Neurofibrosarcoma
1
Interventions
Rituximab
45
Cyclophosphamide
32
Lenalidomide
24
fludarabine
20
zanubrutinib
13
venetoclax
12
obinutuzumab
12
orelabrutinib
11
fludarabine phosphate
10
Bendamustine Hydrochloride
10
Magnetic Resonance Spectroscopy
9
Whole-Body Irradiation
8
Prednisone
8
pirtobrutinib
7
ibrutinib
7
Vincristine
7
Specimen Handling
7
CT-P10
7
Mycophenolic Acid
6
Biopsy
6
Doxorubicin
5
tafasitamab
4
pembrolizumab
3
acalabrutinib
3
Tacrolimus
3
Sirolimus
3
Radiotherapy
3
Peripheral Blood Stem Cell Transplantation
3
Nivolumab
3
Melphalan
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell, Marginal Zone
×
Thiotepa
×
1 year
×
Clear all
No trials found.